Welcome to my home page. I am a registered pharmacist and worked in practice for 10 years prior to joining the staff at the University in 2008. I am interested in the clinical use of medicines, and my predominant teaching role is in the pharmacotherapeutics subjects of the 3rd year of the Undergraduate Pharmacy Program.
My primary research interests are personalised medicine (including pharmacogenomics and drug concentration effect relationships, particularly in patients with rheumatoid arthritis), drug allergy and deprescribing (the process of ceasing redundant medications).
About me
Welcome to my home page. I am a registered pharmacist and worked in practice for 10 years prior to joining the staff at the University in 2008. I am interested in the clinical use of medicines, and my predominant teaching role is in the pharmacotherapeutics subjects of the 3rd year of the Undergraduate Pharmacy Program.
My primary research interests are personalised medicine (including pharmacogenomics and drug concentration effect relationships, particularly in patients with rheumatoid arthritis), drug allergy and deprescribing (the process of ceasing redundant medications).
About me
About me
Doctor of Philosophy University of South Australia
Masters of Clinical Pharmacy University of South Australia
Bachelor of Pharmacy University of South Australia
Research
Excludes commercial-in-confidence projects.
Loading Doses of Methotrexate as Initial Treatment of Rheumatoid Arthritis, Arthritis Australia - Project Grants, 01/01/2025 - 31/12/2025
Translational Venom and Antivenom Research, NHMRC - Centre of Research Excellence, 01/12/2015 - 30/11/2021
Optimisation of the safety and efficacy of protein kinase inhibitors using endogenous and dietary biomarkers, NHMRC - Project Grant, 01/01/2016 - 31/12/2018
Research
Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included. To see earlier years visit ORCID, ResearcherID or Scopus
Open access indicates that an output is open access.
Year | Output |
---|---|
2025 |
Open access
1
|
2025 |
Open access
|
2025 |
Open access
|
2025 |
Maher, D, Reeve, E & Wiese, M 2025, 'Reply', Arthritis Care and Research, online, pp. 1-1.
Open access
|
2025 |
Open access
1
1
|
2025 |
Open access
|
2025 |
1
1
|
2024 |
Open access
3
3
162
|
2024 |
Open access
2
2
|
2024 |
Open access
3
4
|
2024 |
Open access
3
2
39
|
2024 |
2
2
|
2024 |
Open access
|
2024 |
Open access
4
4
239
|
2024 |
Open access
1
5
|
2024 |
Open access
1
1
1
|
2024 |
Open access
1
1
1
|
2024 |
1
2
1
|
2023 |
Open access
3
3
8
|
2023 |
Open access
12
13
2
|
2023 |
Open access
11
|
2023 |
Open access
2
2
5
|
2023 |
Open access
1
1
3
|
2023 |
1
1
|
2022 |
Open access
5
5
1
|
2022 |
Open access
5
5
|
2022 |
Open access
8
7
340
|
2022 |
Open access
7
4
|
2022 |
Open access
17
17
4
|
2022 |
Open access
15
14
1
|
2022 |
Open access
10
9
5
|
2022 |
Open access
16
17
183
|
2022 |
Open access
8
8
8
|
2022 |
Open access
5
6
3
|
2022 |
11
10
1
|
2022 |
Open access
6
5
12
|
2021 |
Open access
1
1
5
|
2021 |
7
7
4
|
2021 |
3
3
|
2021 |
11
9
2
|
2021 |
13
12
1
|
2021 |
Open access
7
7
11
|
2021 |
20
17
|
2021 |
Open access
13
12
1
|
2021 |
Open access
15
15
6
|
2021 |
1
1
|
2021 |
Open access
40
33
7
|
2021 |
Open access
16
15
7
|
2021 |
Open access
34
28
60
|
2021 |
Open access
9
5
12
|
2021 |
Open access
7
7
2
|
2020 |
Open access
26
25
1
|
2020 |
21
22
44
|
2020 |
Open access
9
9
5
|
2020 |
Open access
6
6
2
|
2020 |
11
11
79
|
2020 |
Open access
13
11
3
|
2020 |
14
13
|
2020 |
Open access
10
10
62
|
2020 |
3
3
6
|
2020 |
Open access
8
7
4
|
2020 |
Open access
12
11
3
|
2020 |
Open access
41
40
6
|
2019 |
Open access
35
34
7
|
2019 |
Open access
34
32
2
|
2019 |
Open access
23
27
1
|
2019 |
Open access
7
7
3
|
2018 |
Open access
12
9
4
|
2018 |
Open access
56
52
66
|
2018 |
Open access
14
13
1
|
2018 |
Open access
19
19
1
|
2018 |
16
15
|
2017 |
16
17
3
|
2017 |
Open access
9
9
3
|
2017 |
Open access
151
150
17
|
2017 |
2
2
|
2017 |
Open access
40
34
|
2017 |
4
4
|
2017 |
62
55
1
|
2017 |
4
5
6
|
2017 |
19
16
|
2017 |
23
25
1
|
2017 |
6
6
|
2017 |
12
13
|
2017 |
9
8
|
2017 |
177
155
41
|
2017 |
30
30
6
|
2016 |
Open access
16
14
1
|
2016 |
8
14
|
2016 |
Open access
8
9
|
2016 |
Open access
11
1
|
2016 |
36
32
7
|
2016 |
1
1
|
2016 |
18
11
16
|
2016 |
2
2
10
|
2016 |
12
11
4
|
2016 |
Open access
62
66
6
|
2016 |
Open access
101
97
33
|
2016 |
Open access
|
2015 |
Open access
16
12
|
2015 |
Open access
27
25
|
2015 |
Open access
14
1
|
2015 |
73
56
7
|
2015 |
93
77
3
|
2015 |
Open access
271
246
26
|
2015 |
Open access
442
400
30
|
2015 |
Open access
22
22
|
2015 |
36
35
5
|
2015 |
16
35
12
|
2014 |
6
5
|
2014 |
7
8
|
2014 |
79
69
|
2014 |
Open access
283
261
|
2014 |
Open access
89
66
|
2014 |
21
22
|
2014 |
Open access
106
104
|
2014 |
Open access
52
37
|
2014 |
Open access
24
21
|
2014 |
3
2
|
2014 |
56
52
|
2014 |
44
44
|
2014 |
Open access
6
5
|
2013 |
Open access
14
15
|
2013 |
Open access
54
47
|
2013 |
91
87
|
2013 |
Open access
398
375
|
2013 |
193
172
|
2013 |
13
11
|
2013 |
20
22
|
2013 |
Open access
33
31
|
2013 |
16
15
|
2013 |
64
58
|
2013 |
44
40
|
2012 |
Open access
21
|
2012 |
50
44
|
2012 |
35
31
|
2012 |
24
24
|
2012 |
Open access
40
36
|
2012 |
2
2
|
2011 |
Open access
37
29
|
2011 |
48
43
|
2011 |
|
2011 |
12
12
|
2011 |
Open access
11
11
|
2008 |
17
15
|
2008 |
33
32
|
Year | Output |
---|---|
2024 |
|
2024 |
|
2024 |
|
2024 |
|
Research
External engagement & recognition
Organisation | Country |
---|---|
Advanced Cancer Research Group | AUSTRALIA |
Australian National University | AUSTRALIA |
Baker Heart and Diabetes Institute | AUSTRALIA |
Beker Pharmaceuticals General Business Plc | ETHIOPIA |
Bond University | AUSTRALIA |
Bristol-Myers Squibb, US | AUSTRALIA |
Centre for Eye Research Australia Ltd | AUSTRALIA |
Centre for Translational Physiology | NEW ZEALAND |
Concord Hospital | UNITED STATES |
CSIRO Australia (Commonwealth Scientific Industrial Research organisation) | AUSTRALIA |
Dhhs - Ambulance Tasmania | AUSTRALIA |
Duke University | UNITED STATES |
Federation University Australia | AUSTRALIA |
Flinders Centre for Innovation in Cancer | AUSTRALIA |
Flinders Medical Centre | AUSTRALIA |
Flinders University | AUSTRALIA |
Greenslopes Private Hospital | AUSTRALIA |
James Cook University | AUSTRALIA |
Jimma University | ETHIOPIA |
Karolinska Institute | SWEDEN |
Khon Kaen University | THAILAND |
King Saud University | SAUDI ARABIA |
Macquarie University | AUSTRALIA |
Mahidol University | THAILAND |
Modbury Hospital | AUSTRALIA |
Monash Medical Centre | AUSTRALIA |
Monash University | AUSTRALIA |
Murdoch University | AUSTRALIA |
National Institute of Advanced Industrial Science and Technology | JAPAN |
Northern Adelaide Local Health Network | AUSTRALIA |
NSW Department of Primary Industries | AUSTRALIA |
Oregon Health and Science University | UNITED STATES |
Postgraduate Institute of Medical Education and Research | INDIA |
Prince of Songkla University | THAILAND |
Princess Alexandra Hospital | AUSTRALIA |
Private Individual | UNITED KINGDOM |
Projections Research Inc. | UNITED STATES |
Queensland University of Technology | AUSTRALIA |
Repatriation General Hospital | AUSTRALIA |
Royal Adelaide Hospital | AUSTRALIA |
Royal Hobart Hospital | AUSTRALIA |
SA Pathology | AUSTRALIA |
Shandong First Medical University | CHINA |
Shandong University | CHINA |
South Australian Health and Medical and Research Institute (SAHMRI) | AUSTRALIA |
Stockholm University | SWEDEN |
Suwabus Bessouchi | JAPAN |
Texas Biomedical Research Institute | UNITED STATES |
The Alfred Hospital | AUSTRALIA |
The Hospital for Sick Children | CANADA |
The Queen Elizabeth Hospital | AUSTRALIA |
Tokushima Bunri University | JAPAN |
Univeristy of Toronto | CANADA |
University of Adelaide | AUSTRALIA |
University of Calgary | CANADA |
University of Cambridge | UNITED KINGDOM |
University of Canberra | AUSTRALIA |
University of Manchester | UNITED KINGDOM |
University of Otago | NEW ZEALAND |
University of Pennsylvania | UNITED STATES |
University of Queensland | AUSTRALIA |
University of Sassari | ITALY |
University of Sharjah | UNITED ARAB EMIRATES |
University of Sheffield | UNITED KINGDOM |
University of South Australia | AUSTRALIA |
University of Sydney | AUSTRALIA |
University of Tasmania | AUSTRALIA |
University of Technology Sydney | AUSTRALIA |
University of Toronto | CANADA |
University of Western Australia | AUSTRALIA |
University of Wollongong | AUSTRALIA |
University of Wyoming | UNITED STATES |
Watkins Medical Centre | AUSTRALIA |
Western University | CANADA |
Westmead Hospital | AUSTRALIA |
Women's and Children's Hospital | AUSTRALIA |
External engagement & recognition
Engagement/recognition | Year |
---|---|
MemberAustralian Society of Clinical Immunology and Allergy (ASCIA) |
2017 |
MemberAustralasian Pharmaceutical Science Association (APSA) |
2017 |
Teaching & student supervision
Teaching & student supervision
Supervisions from 2010 shown
Thesis title | Student status |
---|---|
A computational approach to improve the prediction of fraction unbound to enhance pharmacokinetic (PK) and biopharmaceutic models | Current |
Born too soon: Impact on ability to metabolise drugs | Current |
Born too soon: Impact on ability to metabolise drugs | Current |
Comparison of different methods to assess adherence to weekly methotrexate and hydroxychloroquine | Current |
Comparison of skin morphological and physiological profiles in health and disease | Current |
Decorated cubosomes for anti-cancer drugs delivery and targeting | Current |
Development of ex vivo models to predict the efficacy of disease modifying agents in rheumatoid arthritis | Current |
How low can you go? Effect of less oxygen and glucose in the womb on CYP function | Current |
Impact of glucocorticoids on heart development | Current |
Impact of lifelong maternal Western diet on offspring cardiometabolic health | Current |
Navigating gout care in complex and older adult populations | Current |
Pharmacogenomics to achieve precision dosing of fluoropyrimidines (FP) in cancer patients | Current |
Population variability of the omega-3 index and its relevance to chronic inflammatory disease states | Current |
Role of male sex hormones in the placenta | Current |
The impact of poor maternal diets on fetal heart development: identifying targets for intervention | Current |
Therapeutic targeting of Cyp24a1 to mitigate 5-Fluorouracil-induced gastrointestinal mucositis | Current |
Using MRI and deep learning to understand the impact of changes in substrate delivery on brain development | Current |
Using MRI to understand brain development in the fetus | Current |
Vitamin D is the potential treatment for the management of gastrointestinal mucositis | Current |
Assessing patterns and appropriateness of prescription of medications in elderly patients admitted to South Australian Hospitals | Completed |
Development and feasibility of a patient-centred deprescribing process | Completed |
Disease-modifying anti-rheumatic drug therapy in rheumatoid arthritis patients: optimizing therapy and risk prediction | Completed |
Emerging role of pharmacists in preadmission clinics in prevention of postoperative delirium | Completed |
Fetal and maternal drug metabolism in complicated pregnancies | Completed |
Individualisation of leflunomide dosing in rheumatoid arthritis patients | Completed |
Interaction between a suboptimal intrauterine environment and maternal drug use on drug metabolism in the offspring | Completed |
Investigating pharmacometric approaches to individualised medicine in autoimmune diseases | Completed |
Liquid chromatography-tandem mass spectrometry-based bioanalysis to assess toxicological and therapeutic aspects in human disease conditions | Completed |
Molecular regulation of cardiomyocyte maturation | Completed |
Novel methods of analysis of Eastern Russell's viper venom components in human plasma | Completed |
Opioid prescribing in older patients; pharmacoepidemiology and pharmacokinetics | Completed |
Optimising outcomes for patients with rheumatoid arthritis via the use of parenteral methotrexate | Completed |
The role of adherence of physician to treatment strategies and patient to medications in rheumatoid arthritis | Completed |
The role of haptenation in penicillin and cephalosporin allergy | Completed |